Your Location：
Home >
Browse articles >
Regulatory Effect of Guilu Bugu Prescription in Treating Th17/ Treg Cell Factors of Patients with Postmenopausal Osteoporosis Based on Syndrome Differentiation
Regulatory Effect of Guilu Bugu Prescription in Treating Th17/ Treg Cell Factors of Patients with Postmenopausal Osteoporosis Based on Syndrome Differentiation
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 26, Issue 24, Pages: 116-121(2020)
DOI： 10.13422/j.cnki.syfjx.20200933
Scan QR Code
Full Text(HTML)
Figs( 0 ) Tabs( 5 )
References
Publication Info
Metrics
59
Views
106
Downloads
4
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Zuoguiwan Inhibit Bone Resorption in Ovariectomized Rats via STING/TBK1/NF-κB Signaling Pathway
Regulation Effect and Clinical Efficacy of Addition and Subtraction Therapy of Jinkui Shenqiwan Combined with Buzhong Yiqitang on Immune Inflammatory Factors of Patients with Postmenopausal Osteoporosis and Deficiency of Spleen and Kidney
Zuoguiwan Mitigates Oxidative Stress in Rat Model of Hyperthyroidism Due to Kidney-Yin Deficiency via DRD4/NOX4 Pathway
Zuoguiwan Regulates Pdx1 Pathway to Improve Pancreas Development in Offspring of Gestational Diabetes Mellitus Model Rats
Traditional Chinese Medicine Promotes Neoangiogenesis in Treatment of Vascular Dementia by Benefiting Qi， Activating Blood Circulation， and Resolving Blood Stasis： A Review
Related Author
FENG Xiuzhi
YANG Ying
LI Xiaochen
JIA Lianqun
REN Yanling
Yu-lan AN
Chang-xia CAO
Yu-mei TIAN
Related Institution
College of Basic Medical Sciences， Liaoning University of Traditional Chinese Medicine
Qinghai University Affiliated Hospital
Institute of Science and Technology，Guangzhou University of Chinese Medicine
Tong Ren Tang Technologies Co. Ltd.
School of Pharmaceutical Sciences，Guangzhou University of Chinese Medicine
Chat
